|
Acetazolamide Sustained-Release
|
|
Diamox Sequels
|
Acetazolamide Sustained-Release Clinical Trials
- A GCRC Study: A Comparison of the Addiction Liability of Hydrocodone and Sustained Release Morphine
ClinicalTrials.gov Identifier: NCT00314340 - Active, not recruiting
Chronic Pain
- Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
ClinicalTrials.gov Identifier: NCT00307203 - Active, not recruiting
Tobacco-Use Disorder; Schizophrenia; Psychotic Disorders
- Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00478205 - Recruiting
Alzheimer's Disease
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00406640 - Active, not recruiting
Depression; Depressive Disorder; Depressive Disorder, Major
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Vs Placebo in Peri- and Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00369343 - Active, not recruiting
Depression; Depressive Disorder; Depressive Disorder, Major
- A Study of the Effectiveness and Safety of Sustained-Release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.
ClinicalTrials.gov Identifier: NCT00261495 - Active, not recruiting
Pain
- Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
ClinicalTrials.gov Identifier: NCT00418691 - Recruiting
Brain Tumor
- Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients
ClinicalTrials.gov Identifier: NCT00416286 - Not yet recruiting
Healthy
- Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
ClinicalTrials.gov Identifier: NCT00207935 - Recruiting
Epilepsy; Mental Retardation; Developmental Disabilities
- Effects of Sustained Release d-Amphetamine and Buprenorphine on Drug Seeking Behavior in Opioid and Cocaine Dependent Individuals Who Are Not Seeking Treatment
ClinicalTrials.gov Identifier: NCT00429767 - Recruiting
Heroin Dependence; Opioid-Related Disorders; Cocaine Abuse or Dependence
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
Restless Legs Syndrome
- Effects of Acetazolamide and CO2 Inhalation on Exercise-Induced Periodic Breathing in Heart Failure
ClinicalTrials.gov Identifier: NCT00517426 - Recruiting
Chronic Heart Failure
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
ClinicalTrials.gov Identifier: NCT00440427 - Completed
Depressive Disorder, Major
- A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol(CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00361504 - Active, not recruiting
Osteoarthritis; Sciatica; Pain Assessment; Arthralgia
- Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis
ClinicalTrials.gov Identifier: NCT00222534 - Recruiting
Respiratory Insufficiency; Alkalosis
- Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
ClinicalTrials.gov Identifier: NCT00000115 - Completed
Macular Edema, Cystoid
- Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting
Epilepsy
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00207363 - Active, not recruiting
Hepatitis C
- Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
Gastroparesis; Gastroesophageal Reflux Disease
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
ClinicalTrials.gov Identifier: NCT00326144 - Completed
Major Depressive Disorder
- Comparative Study of Modified Release (MR) Tacrolimus/MMF in de novo Kidney Transplant Recipients
ClinicalTrials.gov Identifier: NCT00064701 - Active, not recruiting
Kidney Transplantation
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
ClinicalTrials.gov Identifier: NCT00326105 - Completed
Major Depressive Disorder
- Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation
ClinicalTrials.gov Identifier: NCT00484692 - Completed
Nicotine Dependence; Substance Abuse; Substance Dependence; Tobacco Dependence
- A Randomised, Crossover Study Comparing the Biochemical and Platelet Effects of Modified-Release Dipyridamole/Aspirin (200mg/25 Mg Bd; Asasantin Retard®) with Aspirin (75 Mg Qd) in Coronary Artery Disease Patients with Aspirin Resistance Manifesting
ClinicalTrials.gov Identifier: NCT00129038 - Active, not recruiting
Coronary Arteriosclerosis
- Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00206128 - Completed
Schizophrenia
- A Study to Evaluate LAMICTAL Extended-release Therapy in Patients with Primary Generalized Tonic Clonic Seizures
ClinicalTrials.gov Identifier: NCT00104416 - Active, not recruiting
Tonic-Clonic Seizures; Epilepsy
- A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
ClinicalTrials.gov Identifier: NCT00331149 - Recruiting
Parkinson's Disease
- A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
ClinicalTrials.gov Identifier: NCT00468143 - Not yet recruiting
Attention Deficit Hyperactivity Disorder
- Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
ClinicalTrials.gov Identifier: NCT00056654 - Completed
Prostatic Neoplasms
- Acetaminophen-Induced Hepatotoxicity in Chronic Alcohol Abusers
ClinicalTrials.gov Identifier: NCT00137059 - Completed
hepatotoxicity
- Sleep Apnea: Mechanism and Cerebrovascular Consequences
ClinicalTrials.gov Identifier: NCT00108602 - Recruiting
Stroke; Sleep Apnea, Obstructive
- A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome
ClinicalTrials.gov Identifier: NCT00220363 - Completed
Overactive Bladder Syndrome
- Comparison of IPX054, Immediate-Release Carbidopa-Levodopa, and Controlled-Release Carbidopa-Levodopa in Subjects With Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00279825 - Recruiting
Idiopathic Parkinson's Disease
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
ClinicalTrials.gov Identifier: NCT00215839 - Active, not recruiting
Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections
- An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety and Sustained Efficacy of Denosumab (AMG162) in the Treatment of Postmenopausal Osteoporosis
ClinicalTrials.gov Identifier: NCT00523341 - Recruiting
Osteopenia; Osteoporosis
- Safety and Efficacy of Sustained Erythropoietin Therapy
ClinicalTrials.gov Identifier: NCT00542568 - Not yet recruiting
Anemia
- Tolerability of MK0524A Versus Niacin Extended-Release
ClinicalTrials.gov Identifier: NCT00378833 - Active, not recruiting
Hypercholesterolemia; Hyperlipidemia
- Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
ClinicalTrials.gov Identifier: NCT00420043 - Active, not recruiting
Healthy
- Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase
ClinicalTrials.gov Identifier: NCT00220389 - Completed
Overactive Bladder
- Effect of an Investigational Compound on Tolerability of Extended Release Niacin
ClinicalTrials.gov Identifier: NCT00376584 - Active, not recruiting
Hypercholesteremia; Hyperlipidemia
- A Phase 3, Parallel Group, Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects with Overactive Bladder Syndrome
ClinicalTrials.gov Identifier: NCT00138723 - Completed
Overactive Bladder
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
ClinicalTrials.gov Identifier: NCT00247429 - Active, not recruiting
Depressive Syndrome; Anxiety
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn.
ClinicalTrials.gov Identifier: NCT00255190 - Active, not recruiting
Gastroesophageal Reflux Disease
- Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
ClinicalTrials.gov Identifier: NCT00410748 - Active, not recruiting
Pain; Analgesics, Opioid
- Treatment of High Altitude Polycythemia by Acetazolamide
ClinicalTrials.gov Identifier: NCT00424970 - Not yet recruiting
High Altitude Polycythemia
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
Hypercholesterolemia
- ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
ClinicalTrials.gov Identifier: NCT00461266 - Recruiting
HIV Infections
- A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
ClinicalTrials.gov Identifier: NCT00282256 - Active, not recruiting
Liver Transplantation
- A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
ClinicalTrials.gov Identifier: NCT00282243 - Active, not recruiting
Liver Transplantation
- A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
ClinicalTrials.gov Identifier: NCT00282568 - Active, not recruiting
Kidney Transplantation
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's
ClinicalTrials.gov Identifier: NCT00363727 - Active, not recruiting
Parkinson's Disease; Dyskinesias
- An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)
ClinicalTrials.gov Identifier: NCT00399048 - Active, not recruiting
Osteoarthritis, Knee; Osteoarthritis, Hip
- Safety and Tolerability of Long-Term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
ClinicalTrials.gov Identifier: NCT00410787 - Active, not recruiting
Pain; Analgesics, Opioid
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis
ClinicalTrials.gov Identifier: NCT00411164 - Active, not recruiting
Osteoarthritis, Hip; Osteoarthritis, Knee
- Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
Bipolar Disorder
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in Subjects With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00299715 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
Cerebrovascular Accident
- Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00463619 - Active, not recruiting
Ulcerative Colitis
- 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
Schizophrenia
- Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
Hot Flashes
- Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
Schizophrenia
- Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00187564 - Active, not recruiting
Diabetes Mellitus, Type 1
- Improving Hispanic Retention in Antidepressant Therapy
ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
Depression; Depressive Disorder
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00308139 - Active, not recruiting
Type 2 Diabetes Mellitus
- Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
Carcinoid Tumor; Acromegaly
- Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain
ClinicalTrials.gov Identifier: NCT00411268 - Active, not recruiting
Low Back Pain
- A Study on Efficacyeffectiveness, Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain
ClinicalTrials.gov Identifier: NCT00398788 - Active, not recruiting
Low Back Pain
- Ganciclovir Implant Study for Cytomegalovirus Retinitis
ClinicalTrials.gov Identifier: NCT00000118 - Completed
HIV Infections; Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis
- Splinting for Duupuytren's Contracture Release
ClinicalTrials.gov Identifier: NCT00575458 - Recruiting
Dupuytren's Disease
- Role of Adenosine in the Release of VEGF and Cytokines
ClinicalTrials.gov Identifier: NCT00580905 - Recruiting
Inflammation
- Study to Evaluate a Subcutaneous Four Months Sustained-Release Formulation of Triptorelin in Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00415246 - Terminated
Prostate Cancer
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
Affective Psychosis, Bipolar; Bipolar Disorder; Mania
- Impact of Switching to Continuous Release Dopamine Agonists
ClinicalTrials.gov Identifier: NCT00465452 - Recruiting
Parkinson Disease
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- An Effectiveness and Safety Study of CONCERTA* Vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
ClinicalTrials.gov Identifier: NCT00304681 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
Metabolic Syndrome
- A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
ClinicalTrials.gov Identifier: NCT00446069 - Recruiting
Pain
- The Anti-Inflammatory Effects of High-Fat Nutrition; Towards a Clinical Application
ClinicalTrials.gov Identifier: NCT00468507 - Recruiting
CCK Release
- Study of Extended Release Niacin/Laropiprant on Lipids
ClinicalTrials.gov Identifier: NCT00479388 - Recruiting
Primary Hypercholesterolemia; Mixed Dyslipidemia
- sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial
ClinicalTrials.gov Identifier: NCT00533039 - Recruiting
Coronary Artery Disease
- A Brain Imaging Study Into Nicotine Induced Dopamine Release in Cigarette Smokers.
ClinicalTrials.gov Identifier: NCT00396669 - Recruiting
Tobacco Use Disorder
- The CLEVER Study - Coreg And LEft VEntricular Mass Regression
ClinicalTrials.gov Identifier: NCT00108082 - Active, not recruiting
Hypertension; Left Ventricular Hypertrophy
- Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
ClinicalTrials.gov Identifier: NCT00180765 - Recruiting
Chronic Obstructive Airway Disease; Healthy Volunteers
- Sub-Tenon’s Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
ClinicalTrials.gov Identifier: NCT00431028 - Recruiting
Inflammation; Bacterial Infections
- A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects
ClinicalTrials.gov Identifier: NCT00449709 - Recruiting
Preterm Labor
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
- Carpal Tunnel Syndrome: Diagnosis and Treatment Trial
ClinicalTrials.gov Identifier: NCT00032227 - Active, not recruiting
Carpal Tunnel Syndrome
- Clonidine-Induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain
ClinicalTrials.gov Identifier: NCT00350532 - Recruiting
Pain
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
Atherosclerosis
- A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
ClinicalTrials.gov Identifier: NCT00541658 - Recruiting
Postmenopausal Osteoporosis
- Lamotrigine Extended-Release in Elderly Patients With Epilepsy
ClinicalTrials.gov Identifier: NCT00516139 - Recruiting
Epilepsy
- A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
Schizophrenia
- Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
Hypertension
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
Schizophrenia
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
|